Enlist the medicines with therapeutic claims
Reform ID		F338
Description		Before: Although the Enlistment Rules allow it, DRAP did not grant enlistment to medicines with therapeutic claims, creating regulatory ambiguity and limiting product availability in the market. After: DRAP now enlists and publishes a comprehensive list of medicines approved with therapeutic claims, aligning with global best practices and ensuring transparency and regulatory clarity.
Department		Drug Regulatory Authority of Pakistan - DRAP
Jurisdiction / Location		Federal - Entire Pakistan
Sector		Pharmaceuticals and Healthcare
Start Date		24-06-2025
Target Deadline		09-07-2025
Date Enacted
Implementation Status		Completed
Progress		100%
CCORR Direction		Simplify
Cost Savings PKR (Mil.)
Evidence